Clinical Trial Update: A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial evaluating lamotrigine for neuroprotection in Secondary Progressive Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: University College London Hospitals | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED